Silverback Therapeutics Inc. (NASDAQ: SBTX) Stock Falling -54.85% Over A Month – Any Room For Its Value To Rise? – Marketing Sentinel
Home  »  Business   »  Silverback Therapeutics Inc. (NASDAQ: SBTX) Stock ...

Silverback Therapeutics Inc. (NASDAQ: SBTX) Stock Falling -54.85% Over A Month – Any Room For Its Value To Rise?

Silverback Therapeutics Inc. (NASDAQ:SBTX)’s traded shares stood at 0.31 million during the last session. At the close of trading, the stock’s price was $9.64, to imply a decrease of -4.93% or -$0.5 in intraday trading. The SBTX share’s 52-week high remains $63.41, putting it -557.78% down since that peak but still an impressive 1.04% since price per share fell to its 52-week low of $9.54. The company has a valuation of $288.91M, with an average of 0.57 million shares in intraday trading volume over the past 10 days and average of 370.73K shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Silverback Therapeutics Inc. (SBTX), translating to a mean rating of 1.60. Of 5 analyst(s) looking at the stock, 0 analyst(s) give SBTX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.68.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Silverback Therapeutics Inc. (NASDAQ:SBTX) trade information

After registering a -4.93% downside in the last session, Silverback Therapeutics Inc. (SBTX) has traded red over the past five days. The stock hit a weekly high of 11.19 this Friday, 10/08/21, dropping -4.93% in its intraday price action. The 5-day price performance for the stock is -17.40%, and -54.85% over 30 days. With these gigs, the year-to-date price performance is -79.20%. Short interest in Silverback Therapeutics Inc. (NASDAQ:SBTX) saw shorts transact 3.66 million shares and set a 8.21 days time to cover.

Analysts on Wall Street suggest a consensus price target of $45.40, implying an increase of 78.77% to the stock’s current value. The extremes give us $29.00 and $54.00 for target low and target high price respectively. As such, SBTX has been trading -460.17% off suggested target high and -200.83% from its likely low.

Silverback Therapeutics Inc. (SBTX) estimates and forecasts

Looking at statistics comparing Silverback Therapeutics Inc. share performance against respective industry, we note that the company has outperformed competitors. Silverback Therapeutics Inc. (SBTX) shares are -72.57% down over the last 6 months, with its year-to-date growth rate higher than industry average at 75.55% against 7.00%.

SBTX Dividends

Silverback Therapeutics Inc. has its next earnings report out on May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Silverback Therapeutics Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Silverback Therapeutics Inc. (NASDAQ:SBTX)’s Major holders

Silverback Therapeutics Inc. insiders hold 8.34% of total outstanding shares, with institutional holders owning 86.20% of the shares at 94.04% float percentage. In total, 86.20% institutions holds shares in the company, led by Orbimed Advisors LLC. As of Jun 29, 2021, the company held over 8.74 million shares (or 24.95% of shares), all amounting to roughly $270.01 million.

The next major institution holding the largest number of shares is FMR, LLC with 4.69 million shares, or about 13.38% of shares outstanding. As of the market price on Jun 29, 2021, these shares were worth $144.81 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have Fidelity Growth Company Fund and Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund as the top two Mutual Funds with the largest holdings of the Silverback Therapeutics Inc. (SBTX) shares. Going by data provided on Jul 30, 2021, Fidelity Growth Company Fund holds roughly 1.41 million shares. This is just over 4.02% of the total shares, with a market valuation of $42.63 million. Data from the same date shows that the other fund manager holds a little less at 0.37 million, or 1.06% of the shares, all valued at about 11.47 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam